Showing results (41-50 of 131) with videos related to
Sort By:
Pageof 14
Clinical Trials (London, England)|July 9, 2015
Characteristics of clinical trials that require participants to be fluent in EnglishBrian L Egleston, Omar Pedraza, Yu-Ning Wong, et al.Clinical Genitourinary Cancer|September 2, 2019
Results of a Real-world Study of Enzalutamide and Abiraterone Acetate With Prednisone Tolerability (REAAcT)Neal D Shore, Daniel Saltzstein, Paul Sieber, et al.Journal of the American College of Surgeons|July 17, 2014
Skin involvement and breast cancer: are T4b lesions of all sizes created equal?Diana Silverman, Karen Ruth, Elin R Sigurdson, et al.Cancer|June 1, 2021
Long-term depression incidence and associated mortality among African American and White prostate cancer survivorsRavi B Parikh, Joseph J Gallo, Yu-Ning Wong, et al.Annals of Surgical Oncology|August 11, 2012
Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare populationMargaret L Crivello, Karen Ruth, Elin R Sigurdson, et al.Journal of Genetic Counseling|May 6, 2014
Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testingJennifer M Matro, Karen J Ruth, Yu-Ning Wong, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2016
The Parity Paradigm: Can Legislation Help Reduce the Cost Burden of Oral Anticancer Medications?Sheetal M Kircher, Caitlin R Meeker, Halla Nimeiri, et al.Cancer|September 27, 2012
Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer NetworkRachel A Freedman, Melissa E Hughes, Rebecca A Ottesen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast CancerAndrew J Epstein, Yu-Ning Wong, Nandita Mitra, et al.The Oncologist|April 1, 2011
Continued use of trastuzumab beyond disease progression in the national comprehensive cancer network: should we practice ahead of the evidence?Yu-Ning Wong, Rebecca A Ottesen, Melissa E Hughes, et al.Pageof 14